Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine*
- 1 March 2006
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (3) , 676-681
- https://doi.org/10.1097/01.ccm.0000201403.70636.0f
Abstract
Because several experimental studies have demonstrated that cyclic adenosine monophosphate generation following β-adrenoceptor activation can markedly stimulate alveolar fluid clearance, we determined whether the endogenous levels of catecholamines that occur in the pulmonary edema fluid and plasma of patients with acute lung injury are high enough to stimulate alveolar fluid clearance in the human lung. Observational clinical study. Academic university hospital and laboratory. Twenty-one patients with acute pulmonary edema plus ex vivo human lungs. Measurements of catecholamine levels in patient samples and controlled laboratory studies of the effects of these catecholamine levels on the rates of alveolar fluid clearance in ex vivo human lungs. The concentrations of both epinephrine and norepinephrine in the pulmonary edema fluid and plasma were ∼10−9 M (range of 1–8 × 10−9 M) in hydrostatic pulmonary edema (n = 6) and acute lung injury patients (n = 15). We therefore tested whether 10−9 M epinephrine or norepinephrine stimulated alveolar fluid clearance in isolated human lungs and found that these epinephrine or norepinephrine concentrations did not stimulate alveolar fluid clearance. However, higher concentrations of epinephrine (10−7 M), but not norepinephrine (10−7 M), significantly stimulated alveolar fluid clearance by 84% above control. Glibenclamide (10−5 M) and CFTRinh-172 (10−5 M), cystic fibrosis transmembrane conductance regulator inhibitors, completely inhibited the epinephrine-induced stimulation of alveolar fluid clearance. These results indicate that endogenous catecholamine concentrations in pulmonary edema fluid are probably not sufficient to stimulate alveolar fluid clearance. In contrast, administration of exogenous catecholamines into the distal airspaces can stimulate alveolar fluid clearance in the human lung, an effect that is mediated in part by cystic fibrosis transmembrane conductance regulator. Therefore, exogenous cyclic adenosine monophosphate-dependent stimulation will probably be required to accelerate the resolution of alveolar edema in the lungs of patients with pulmonary edema.Keywords
This publication has 22 references indexed in Scilit:
- Interdependency of β-Adrenergic Receptors and CFTR in Regulation of Alveolar Active Na + TransportCirculation Research, 2005
- CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitorAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Norepinephrine Increases Alveolar Fluid Reabsorption and Na,K-ATPase ActivityAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Clinically relevant concentrations of β2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury*Critical Care Medicine, 2004
- A small molecule CFTR inhibitor produces cystic fibrosis‐like submucosal gland fluid secretions in normal airwaysThe FASEB Journal, 2004
- Salmeterol for the Prevention of High-Altitude Pulmonary EdemaNew England Journal of Medicine, 2002
- Alveolar Fluid Clearance Is Impaired in the Majority of Patients with Acute Lung Injury and the Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Alveolar Epithelial TransportAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Alveolar fluid clearance in the resected human lung.American Journal of Respiratory and Critical Care Medicine, 1994
- Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats.Journal of Clinical Investigation, 1994